Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens**The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.††Supported by Clinical Research Program Center grant no. 730 from the Upjohn Company, Kalamazoo, Michigan.‡‡Presented at the 45th Annual Meeting of The American Fertility Society, San Francisco, California, November 13 to 16, 1989.